BASILE, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 1.062
NA - Nord America 855
AS - Asia 759
SA - Sud America 142
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.837
Nazione #
US - Stati Uniti d'America 815
RU - Federazione Russa 686
SG - Singapore 264
CN - Cina 251
BR - Brasile 116
IT - Italia 94
HK - Hong Kong 75
VN - Vietnam 69
DE - Germania 56
SE - Svezia 54
FR - Francia 39
IN - India 34
FI - Finlandia 30
GB - Regno Unito 27
CA - Canada 22
NL - Olanda 22
JP - Giappone 18
MX - Messico 17
PL - Polonia 15
BD - Bangladesh 9
ES - Italia 9
IQ - Iraq 8
ZA - Sudafrica 8
AR - Argentina 7
EC - Ecuador 7
ID - Indonesia 7
IE - Irlanda 6
LT - Lituania 5
BE - Belgio 4
TR - Turchia 4
UZ - Uzbekistan 4
VE - Venezuela 4
AT - Austria 3
CO - Colombia 3
MD - Moldavia 3
PH - Filippine 3
SA - Arabia Saudita 3
TN - Tunisia 3
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
PK - Pakistan 2
PY - Paraguay 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
Totale 2.837
Città #
Singapore 151
Dallas 123
Ashburn 106
Moscow 101
San Jose 91
Hong Kong 74
New York 57
Shanghai 44
Beijing 35
Los Angeles 32
Milan 30
Munich 30
Boardman 29
Ho Chi Minh City 28
Hefei 25
Turku 23
Lauterbourg 20
São Paulo 15
Hanoi 14
Santa Clara 14
Brooklyn 13
Tokyo 13
Denver 12
Orem 12
Warsaw 12
Guangzhou 11
Lawrence 11
Princeton 11
Rome 10
Amsterdam 9
Chennai 8
Frankfurt am Main 8
Mexico City 8
Montreal 8
Pune 8
Houston 7
Johannesburg 7
London 7
Manchester 7
Phoenix 7
Toronto 7
Atlanta 6
Columbus 6
Mumbai 6
Seattle 6
The Dalles 6
Da Nang 5
Dublin 5
Helsinki 5
Nuremberg 5
Stockholm 5
Barnet 4
Brussels 4
Erbil 4
Falkenstein 4
Guayaquil 4
Haiphong 4
Hyderabad 4
Poplar 4
San Francisco 4
Shenzhen 4
Tashkent 4
Belo Horizonte 3
Boston 3
Buffalo 3
Caxias do Sul 3
Cesano Boscone 3
Charlotte 3
Hanover 3
Querétaro 3
Rio de Janeiro 3
Riyadh 3
Turin 3
Washington 3
Acalanes Ridge 2
Ankara 2
Baltimore 2
Bexley 2
Biên Hòa 2
Bologna 2
Bến Tre 2
Cancello e Arnone 2
Carpi 2
Catania 2
Cerano 2
Chaam 2
Cleveland 2
Council Bluffs 2
Dalian 2
Delhi 2
Detroit 2
Duque de Caxias 2
Hải Dương 2
Jackson 2
Karbala 2
Lappeenranta 2
Mariana 2
Medellín 2
Milwaukee 2
New Delhi 2
Totale 1.425
Nome #
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 180
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 160
A global approach to improving penile cancer care 136
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 134
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 129
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 125
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 123
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 123
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 122
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 120
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 119
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 117
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 115
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 109
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 108
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 104
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 102
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 100
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 99
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 96
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 95
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 93
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 85
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 66
The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis 59
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer 36
First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC) 18
Diagnostic and treatment delays in penile cancer: a call to improve awareness and referral 4
Neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by adjuvant pembrolizumab, in patients with muscle-invasive bladder cancer (SURE-02): a single-arm, phase 2 study 3
Data from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial 2
Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer 2
null 1
Totale 2.885
Categoria #
all - tutte 12.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 0 5 0 6 2 0 1 0 1 0 0 9
2022/2023100 27 18 3 7 4 12 8 11 2 0 4 4
2023/2024241 12 20 22 19 15 47 1 40 5 9 14 37
2024/2025483 33 21 16 29 31 41 66 62 70 28 32 54
2025/20262.033 121 124 125 240 182 67 156 188 573 131 68 58
Totale 2.885